[go: up one dir, main page]

UA101312C2 - Модуляторы фармакокинетических свойств терапевтических препаратов - Google Patents

Модуляторы фармакокинетических свойств терапевтических препаратов

Info

Publication number
UA101312C2
UA101312C2 UAA200909677A UAA200909677A UA101312C2 UA 101312 C2 UA101312 C2 UA 101312C2 UA A200909677 A UAA200909677 A UA A200909677A UA A200909677 A UAA200909677 A UA A200909677A UA 101312 C2 UA101312 C2 UA 101312C2
Authority
UA
Ukraine
Prior art keywords
therapeutics
modulators
pharmacokinetic properties
compounds
administration
Prior art date
Application number
UAA200909677A
Other languages
English (en)
Ukrainian (uk)
Inventor
Маной К. Дізай
Аллен Й. Хонг
Хон К. Хуі
Хонгтао Ліу
Рендалл У. Вівіан
Ліанхонг Ксу
Original Assignee
Гіліад Сайєнсіз, Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46465350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA101312(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Гіліад Сайєнсіз, Інк. filed Critical Гіліад Сайєнсіз, Інк.
Priority claimed from PCT/US2008/054788 external-priority patent/WO2008103949A1/en
Publication of UA101312C2 publication Critical patent/UA101312C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение касается производных таизола, их фармацевтически приемлемых солей, сольватов и/или эстеров, композиций, которые включают данные соединения, способов лечения, которые включают введение данных соединений, способов лечения, которые включают введение данных соединений с по меньшей мере одним дополнительным лекарственным средством.
UAA200909677A 2007-02-23 2008-02-22 Модуляторы фармакокинетических свойств терапевтических препаратов UA101312C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90322807P 2007-02-23 2007-02-23
PCT/US2008/054788 WO2008103949A1 (en) 2007-02-23 2008-02-22 Modulators of pharmacokinetic properties of therapeutics

Publications (1)

Publication Number Publication Date
UA101312C2 true UA101312C2 (ru) 2013-03-25

Family

ID=46465350

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200909677A UA101312C2 (ru) 2007-02-23 2008-02-22 Модуляторы фармакокинетических свойств терапевтических препаратов

Country Status (8)

Country Link
EP (6) EP2487163B1 (ru)
DK (3) DK2487162T3 (ru)
HU (2) HUS1600053I1 (ru)
ME (4) ME02631B (ru)
PL (2) PL2487166T3 (ru)
RS (4) RS55459B1 (ru)
SI (4) SI2487162T1 (ru)
UA (1) UA101312C2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015503624A (ja) * 2012-01-12 2015-02-02 ギリアード サイエンシーズ， インコーポレイテッド 医薬組成物およびその調製方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
ATE429224T1 (de) 1999-06-04 2009-05-15 Abbott Lab Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor
ES2796275T3 (es) 2006-07-07 2020-11-26 Gilead Sciences Inc Moduladores de propiedades farmacocinéticas de agentes terapéuticos
ES2601820T5 (es) 2007-02-23 2024-10-31 Gilead Sciences Inc Moduladores de propiedades terapéutica de las farmacocinéticas

Also Published As

Publication number Publication date
EP2487163B1 (en) 2016-08-17
HUS1600052I1 (hu) 2017-01-30
RS55195B1 (sr) 2017-01-31
DK2487161T3 (en) 2016-10-24
ME02582B (me) 2017-06-20
EP2487163A1 (en) 2012-08-15
RS55280B1 (sr) 2017-03-31
DK2487161T4 (da) 2024-06-24
SI2487163T1 (sl) 2016-12-30
DK2487163T3 (en) 2016-10-24
SI2487162T1 (sl) 2016-12-30
DK2487162T3 (en) 2016-10-24
RS55351B2 (sr) 2024-09-30
EP2487166B1 (en) 2016-07-27
EP2487166A1 (en) 2012-08-15
EP2487164A1 (en) 2012-08-15
HUS1600053I1 (hu) 2017-01-30
PL2487163T3 (pl) 2017-04-28
PL2487166T3 (pl) 2017-07-31
EP2487168A1 (en) 2012-08-15
EP2487162B1 (en) 2016-08-17
ME02631B (me) 2017-06-20
RS55459B1 (sr) 2017-04-28
SI2487161T1 (sl) 2016-12-30
EP2487162A1 (en) 2012-08-15
RS55351B1 (sr) 2017-03-31
ME02628B (me) 2017-06-20
SI2487161T2 (sl) 2024-07-31
ME02680B (me) 2017-06-20
EP2487167A1 (en) 2012-08-15
SI2487166T1 (sl) 2017-02-28

Similar Documents

Publication Publication Date Title
MX2009008935A (es) Moduladores de las propiedades farmacocineticas de productos terapeuticos.
WO2008010921A3 (en) Modulators of pharmacokinetic properties of therapeutics
PT2038290E (pt) Moduladores de receptor do tipo toll 7
EA200971081A1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
UA94964C2 (ru) Производные 5-замещенного хиназолинона, композиция, которая их содержит, и их применение
TN2013000253A1 (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
NZ593110A (en) pteridinone derivatives as MODULATORS OF TOLL-LIKE RECEPTORS
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
MX2011011136A (es) Eteres diarilicos.
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
MY149622A (en) Pyrazoles as 11-beta-hsd-1
PL2054411T3 (pl) Nowe związki, ich izomery lub ich farmaceutycznie dopuszczalne sole jako antagoniści receptora waniloidowego oraz zawierające je kompozycje farmaceutyczne
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
UA94606C2 (ru) Производные тиоксантина, композиция, которая их содержит, и их применение в терапии
NZ593440A (en) Aminopyrazole compounds useful for inhibiting chk1
PT2310356E (pt) Derivados de adamantildiamida e a sua utilização
MX2009011578A (es) 6-fenilpirimidinonas como moduladores de pim.
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
MX2010001574A (es) Ligandos del receptor cannabinoide.
TN2015000279A1 (en) Tricyclic compounds for inhibiting the cftr channel
WO2009140341A3 (en) Atorvastatin compositions
MX2009003169A (es) Derivados de sulfonamida.
WO2011042473A3 (en) Estrogen receptor ligands
UA101312C2 (ru) Модуляторы фармакокинетических свойств терапевтических препаратов
UA97112C2 (ru) Модуляторы фармакокинетических свойств лекарственных средств